Mesothelioma (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Mesothelioma" in English language version.

refsWebsite

Global rank English rank

96nih.gov

4^th place

66doi.org

2^nd place

26web.archive.org

1^st place

16semanticscholar.org

11^th place

8^th place

4cancer.gov

1,684^th place

1,350^th place

4cdc.gov

218^th place

212^th place

3handle.net

102^nd place

76^th place

2cancer.org

3,680^th place

2,918^th place

2harvard.edu

18^th place

17^th place

2nytimes.com

7^th place

2congress.gov

730^th place

468^th place

1books.google.com

3^rd place

1mountsinai.org

low place

1scientificamerican.com

896^th place

674^th place

1worldcat.org

5^th place

1who.int

195^th place

302^nd place

1zenodo.org

621^st place

380^th place

1epa.gov

882^nd place

600^th place

1hse.gov.uk

8,579^th place

5,055^th place

1archive.org

6^th place

1prwatch.org

low place

1rcn.com

low place

1utsouthwestern.edu

low place

1jtcvs.org

low place

1fda.gov

447^th place

338^th place

1surgicaloncology.com

low place

1clinicalkey.com

low place

1rand.org

2,921^st place

2,118^th place

1cancerresearchuk.org

8,489^th place

6,122^nd place

1independent.co.uk

36^th place

33^rd place

1bbc.co.uk

8^th place

10^th place

1laweekly.com

890^th place

548^th place

1smh.com.au

132^nd place

96^th place

1newcastleherald.com.au

low place

7,939^th place

1iol.co.za

1,318^th place

794^th place

1kb.nl

1,689^th place

4,235^th place

1asbestosdiseases.org.au

low place

1junehancockfund.org

low place

archive.org

Fishman's Pulmonary Diseases and Disorders (4th ed.). McGraw-Hill. 2008. p. 1537. ISBN 978-0-07-145739-2.

asbestosdiseases.org.au

"Wittenoom Chronology - Asbestos Diseases Society of Australia Inc". asbestosdiseases.org.au. Retrieved 2024-04-15.

bbc.co.uk

news.bbc.co.uk

"Asbestos 'did not kill' producer". BBC News. 10 June 2003.

books.google.com

Whittemore AS (2006). Cancer epidemiology and prevention (3rd ed.). Oxford: Oxford University Press. p. 669. ISBN 978-0-19-974797-9.

cancer.gov

"Malignant Mesothelioma Treatment – Patient Version (PDQ®)". NCI. September 4, 2015. Archived from the original on 5 April 2016. Retrieved 3 April 2016.
"Malignant Mesothelioma Treatment – Patient Version (PDQ®)". NCI. September 4, 2015. Archived from the original on 5 April 2016. Retrieved 3 April 2016.
"Malignant Mesothelioma – Patient Version". NCI. January 1980. Archived from the original on 6 April 2016. Retrieved 3 April 2016.

seer.cancer.gov

"Age-Adjusted SEER Incidence and U.S. Death Rates and 5-Year Relative Survival (Percent) By Primary Cancer Site, Sex and Time Period" (PDF). NCI. Archived (PDF) from the original on 6 September 2015. Retrieved 3 April 2016.

cancer.org

"What are the key statistics about malignant mesothelioma?". American Cancer Society. 2016-02-17. Archived from the original on 8 April 2016. Retrieved 3 April 2016.
"Survival statistics for mesothelioma". cancer.org. 17 February 2016. Archived from the original on 6 November 2016. Retrieved 28 November 2016.

cancerresearchuk.org

"Mesothelioma statistics". Cancer Research UK. 2015-05-14. Archived from the original on 30 October 2014. Retrieved 28 October 2014.

cdc.gov

"NIOSH Working Group Paper" (PDF). U.S. Centers for Disease Control and prevention. 1980. Archived from the original (PDF) on 2017-06-18.
"Protecting Workers' Families: A Research Agenda of the Workers' Family Protection Task Force". National Institute for Occupational Safety and Health. DHHS (NIOSH). May 2002. Publication No. 2002-113. Archived from the original on 2017-06-19.

blogs.cdc.gov

Weissman D, Kiefer M (22 November 2011). "Erionite: An Emerging North American Hazard". National Institute for Occupational Safety and Health. Archived from the original on 5 September 2015.

atsdr.cdc.gov

Agency for Toxic Substances and Disease Registry (ATSDR) (2001). Toxicological profile for Asbestos (PDF) (Report). Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service.

clinicalkey.com

Ambrogi MC, Bertoglio P, Aprile V (2018). "Diaphragm and lung–preserving surgery with hyperthermic chemotherapy for malignant pleural mesothelioma: A 10-year experience". The Journal of Thoracic and Cardiovascular Surgery. 155 (4): 1857–1866.e2. doi:10.1016/j.jtcvs.2017.10.070. hdl:11568/888183. PMID 29191688. Retrieved 1 March 2018.

congress.gov

beta.congress.gov

"H.R.982 - 113th Congress (2013-2014): Furthering Asbestos Claim Transparency (FACT) Act of 2013 - Congress.gov - Library of Congress". Library of Congress. 2013-11-14. Archived from the original on 24 July 2014. Retrieved 20 October 2014.

congress.gov

"H.R.526 - 114th Congress (2015-2016): Furthering Asbestos Claim Transparency (FACT) Act of 2015 - Congress.gov - Library of Congress". Library of Congress. 2015-11-30. Archived from the original on 2015-09-07. Retrieved 1 Dec 2015.

doi.org

Kondola S, Manners D, Nowak AK (June 2016). "Malignant pleural mesothelioma: an update on diagnosis and treatment options". Therapeutic Advances in Respiratory Disease. 10 (3): 275–288. doi:10.1177/1753465816628800. PMC 5933604. PMID 26873306.
Robinson BM (November 2012). "Malignant pleural mesothelioma: an epidemiological perspective". Annals of Cardiothoracic Surgery. 1 (4): 491–496. doi:10.3978/j.issn.2225-319X.2012.11.04. PMC 3741803. PMID 23977542.
Vilchez RA, Butel JS (July 2004). "Emergent human pathogen simian virus 40 and its role in cancer". Clinical Microbiology Reviews. 17 (3): 495–508. doi:10.1128/CMR.17.3.495-508.2004. PMC 452549. PMID 15258090.
Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, et al. (GBD 2015 Disease and Injury Incidence and Prevalence Collaborators) (October 2016). "Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577. PMID 27733282.
Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al. (GBD 2015 Mortality and Causes of Death Collaborators) (October 2016). "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1459–1544. doi:10.1016/s0140-6736(16)31012-1. PMC 5388903. PMID 27733281.
Panou V, Vyberg M, Weinreich UM, Meristoudis C, Falkmer UG, Røe OD (June 2015). "The established and future biomarkers of malignant pleural mesothelioma". Cancer Treatment Reviews. 41 (6): 486–495. doi:10.1016/j.ctrv.2015.05.001. PMID 25979846.
Gulati M, Redlich CA (March 2015). "Asbestosis and environmental causes of usual interstitial pneumonia". Current Opinion in Pulmonary Medicine. 21 (2): 193–200. doi:10.1097/MCP.0000000000000144. PMC 4472384. PMID 25621562.
Raza A, Huang WC, Takabe K (September 2014). "Advances in the management of peritoneal mesothelioma". World Journal of Gastroenterology. 20 (33): 11700–11712. doi:10.3748/wjg.v20.i33.11700. PMC 4155360. PMID 25206274.
Cedrés S, Fariñas L, Stejpanovic N, Martinez P, Martinez A, Zamora E, et al. (April 2013). "Bone metastases with nerve root compression as a late complication in patient with epithelial pleural mesothelioma". Journal of Thoracic Disease. 5 (2): E35 – E37. doi:10.3978/j.issn.2072-1439.2012.07.08. PMC 3621936. PMID 23585954.
Attanoos RL, Churg A, Galateau-Salle F, Gibbs AR, Roggli VL (June 2018). "Malignant Mesothelioma and Its Non-Asbestos Causes". Archives of Pathology & Laboratory Medicine. 142 (6): 753–760. doi:10.5858/arpa.2017-0365-RA. PMID 29480760.
Constantopoulos SH (October 2008). "Environmental mesothelioma associated with tremolite asbestos: lessons from the experiences of Turkey, Greece, Corsica, New Caledonia and Cyprus". Regulatory Toxicology and Pharmacology. 52 (1 Suppl): S110 – S115. doi:10.1016/j.yrtph.2007.11.001. PMID 18171598.
Dogan U (2003). "Mesothelioma in Cappadocian villages". Indoor and Built Environment. 12 (6): 367–375. doi:10.1177/1420326X03039065. ISSN 1420-326X. S2CID 110334356.
Carbone M, Emri S, Dogan AU, Steele I, Tuncer M, Pass HI, et al. (February 2007). "A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes". Nature Reviews. Cancer. 7 (2): 147–154. doi:10.1038/nrc2068. PMID 17251920. S2CID 9440201.
"Asbestos fibers and other elongate mineral particles: state of the science and roadmap for research". Current Intelligence Bulletin 62. 10 July 2020. doi:10.26616/NIOSHPUB2011159.
Kanarek MS (September 2011). "Mesothelioma from chrysotile asbestos: update". Annals of Epidemiology. 21 (9): 688–697. doi:10.1016/j.annepidem.2011.05.010. PMID 21820631.
Roggli VL, Sharma A, Butnor KJ, Sporn T, Vollmer RT (2002). "Malignant mesothelioma and occupational exposure to asbestos: a clinicopathological correlation of 1445 cases". Ultrastructural Pathology. 26 (2): 55–65. doi:10.1080/01913120252959227. PMID 12036093. S2CID 25204873.
Gennaro V, Finkelstein MM, Ceppi M, Fontana V, Montanaro F, Perrotta A, et al. (March 2000). "Mesothelioma and lung tumors attributable to asbestos among petroleum workers". American Journal of Industrial Medicine. 37 (3): 275–282. doi:10.1002/(SICI)1097-0274(200003)37:3<275::AID-AJIM5>3.0.CO;2-I. PMID 10642417.
Henderson DW, Rödelsperger K, Woitowitz HJ, Leigh J (December 2004). "After Helsinki: a multidisciplinary review of the relationship between asbestos exposure and lung cancer, with emphasis on studies published during 1997–2004". Pathology. 36 (6): 517–550. doi:10.1080/00313020400010955. PMID 15841689. S2CID 35280387.
Hillerdal G (August 1999). "Mesothelioma: cases associated with non-occupational and low dose exposures". Occupational and Environmental Medicine. 56 (8): 505–513. doi:10.1136/oem.56.8.505. PMC 1757769. PMID 10492646.
Peto J, Seidman H, Selikoff IJ (January 1982). "Mesothelioma mortality in asbestos workers: implications for models of carcinogenesis and risk assessment". British Journal of Cancer. 45 (1): 124–135. doi:10.1038/bjc.1982.15. PMC 2010947. PMID 7059455.
Carbone M, Ly BH, Dodson RF, Pagano I, Morris PT, Dogan UA, et al. (January 2012). "Malignant mesothelioma: facts, myths, and hypotheses". Journal of Cellular Physiology. 227 (1): 44–58. doi:10.1002/jcp.22724. PMC 3143206. PMID 21412769.
Burdorf A, Dahhan M, Swuste P (August 2003). "Occupational characteristics of cases with asbestos-related diseases in The Netherlands". The Annals of Occupational Hygiene. 47 (6): 485–492. doi:10.1093/annhyg/meg062. hdl:1765/10196. PMID 12890657.
Glover J (April 1973). "Hygiene standards for airborne amosite asbestos dust. British Occupational Hygiene Society Committee on Hygiene Standards". The Annals of Occupational Hygiene. 16 (1): 1–5. doi:10.1093/annhyg/16.1.1. PMID 4775386.
Berry G, Reid A, Aboagye-Sarfo P, de Klerk NH, Olsen NJ, Merler E, et al. (February 2012). "Malignant mesotheliomas in former miners and millers of crocidolite at Wittenoom (Western Australia) after more than 50 years follow-up". British Journal of Cancer. 106 (5): 1016–1020. doi:10.1038/bjc.2012.23. PMC 3305966. PMID 22315054.
Peipins LA, Lewin M, Campolucci S, Lybarger JA, Miller A, Middleton D, et al. (November 2003). "Radiographic abnormalities and exposure to asbestos-contaminated vermiculite in the community of Libby, Montana, USA". Environmental Health Perspectives. 111 (14): 1753–1759. Bibcode:2003EnvHP.111.1753P. doi:10.1289/ehp.6346. PMC 1241719. PMID 14594627.
Testa JR, Cheung M, Pei J, Below JE, Tan Y, Sementino E, et al. (August 2011). "Germline BAP1 mutations predispose to malignant mesothelioma". Nature Genetics. 43 (10): 1022–1025. doi:10.1038/ng.912. PMC 3184199. PMID 21874000.
Mutsaers SE (September 2002). "Mesothelial cells: their structure, function and role in serosal repair". Respirology. 7 (3): 171–191. doi:10.1046/j.1440-1843.2002.00404.x. PMID 12153683. S2CID 23976724.
Miserocchi G, Sancini G, Mantegazza F, Chiappino G (January 2008). "Translocation pathways for inhaled asbestos fibers". Environmental Health. 7 (1): 4. Bibcode:2008EnvHe...7....4M. doi:10.1186/1476-069X-7-4. PMC 2265277. PMID 18218073.
Chiosea S, Krasinskas A, Cagle PT, Mitchell KA, Zander DS, Dacic S (June 2008). "Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas". Modern Pathology. 21 (6): 742–747. doi:10.1038/modpathol.2008.45. PMID 18327208. S2CID 7743919.
Sherr CJ (September 2006). "Divorcing ARF and p53: an unsettled case". Nature Reviews. Cancer. 6 (9): 663–673. doi:10.1038/nrc1954. PMID 16915296. S2CID 29465278.
Dehé PM, Gaillard PH (May 2017). "Control of structure-specific endonucleases to maintain genome stability". Nature Reviews Molecular Cell Biology. 18 (5): 315–330. doi:10.1038/nrm.2016.177. PMID 28327556. S2CID 24009279.
Bueno, Stawiski, Goldstein, Durinck, De Rienzo (2016). "Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations". Nature Genetics. 48 (4): 407–416. doi:10.1038/ng.3520. PMID 26928227. S2CID 13480173.
Mangiante, Alcala, Sexton-Oates, Di Genova, Gonzalez-Perez (2023). "Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity". Nature Genetics. 55 (4): 607–618. doi:10.1038/s41588-023-01321-1. PMC 10101853. PMID 36928603. S2CID 257582839.
Davidson B (June 2015). "Prognostic factors in malignant pleural mesothelioma". Human Pathology. 46 (6): 789–804. doi:10.1016/j.humpath.2015.02.006. PMID 25824607.
Reid G (June 2015). "MicroRNAs in mesothelioma: from tumour suppressors and biomarkers to therapeutic targets". Journal of Thoracic Disease. 7 (6): 1031–1040. doi:10.3978/j.issn.2072-1439.2015.04.56. PMC 4466421. PMID 26150916.
Comertpay S, Pastorino S, Tanji M, Mezzapelle R, Strianese O, Napolitano A, et al. (December 2014). "Evaluation of clonal origin of malignant mesothelioma". Journal of Translational Medicine. 12: 301. doi:10.1186/s12967-014-0301-3. PMC 4255423. PMID 25471750.
Weder W (October 2010). "Mesothelioma". Annals of Oncology. 21 (7): vii326 – vii333. doi:10.1093/annonc/mdq471. PMID 20943637.
Ceresoli GL, Gridelli C, Santoro A (July 2007). "Multidisciplinary treatment of malignant pleural mesothelioma". The Oncologist. 12 (7): 850–863. doi:10.1634/theoncologist.12-7-850. PMID 17673616. S2CID 41668550.
Berzenji L, Van Schil PE, Carp L (October 2018). "The eighth TNM classification for malignant pleural mesothelioma". Translational Lung Cancer Research. 7 (5): 543–549. doi:10.21037/tlcr.2018.07.05. PMC 6204412. PMID 30450292.
Robinson BW, Creaney J, Lake R, Nowak A, Musk AW, de Klerk N, et al. (July 2005). "Soluble mesothelin-related protein--a blood test for mesothelioma". Lung Cancer. 49 (Suppl 1): S109 – S111. doi:10.1016/j.lungcan.2005.03.020. PMID 15950789.
Beyer HL, Geschwindt RD, Glover CL, Tran L, Hellstrom I, Hellstrom KE, et al. (April 2007). "MESOMARK: a potential test for malignant pleural mesothelioma". Clinical Chemistry. 53 (4): 666–672. doi:10.1373/clinchem.2006.079327. PMID 17289801.
Milosevic V, Kopecka J, Salaroglio IC, Libener R, Napoli F, Izzo S, et al. (2020). "Wnt/IL-1β/IL-8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5". International Journal of Cancer. 146 (1): 192–207. doi:10.1002/ijc.32419. hdl:2318/1711962. PMID 31107974. S2CID 160014053.
Haber SE, Haber JM (2011). "Malignant mesothelioma: a clinical study of 238 cases". Industrial Health. 49 (2): 166–172. doi:10.2486/indhealth.MS1147. PMID 21173534.
Chapman E, Berenstein EG, Diéguez M, Ortiz Z (July 2006). "Radiotherapy for malignant pleural mesothelioma". The Cochrane Database of Systematic Reviews. 2010 (3): CD003880. doi:10.1002/14651858.CD003880.pub4. PMC 8746191. PMID 16856023. S2CID 26025607.
Borasio P, Berruti A, Billé A, Lausi P, Levra MG, Giardino R, et al. (February 2008). "Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients". European Journal of Cardio-Thoracic Surgery. 33 (2): 307–313. doi:10.1016/j.ejcts.2007.09.044. PMID 18164622.
Tilleman RT, Richards WG (2009). "Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: A phase II prospective study". JTCVS. 138 (2): 405–11. doi:10.1016/j.jtcvs.2009.02.046. PMID 19619785.
Allen AM, Czerminska M, Jänne PA, Sugarbaker DJ, Bueno R, Harris JR, et al. (1 July 2006). "Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma". International Journal of Radiation Oncology, Biology, Physics. 65 (3): 640–645. doi:10.1016/j.ijrobp.2006.03.012. PMID 16751058.
Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, et al. (July 2003). "Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma". Journal of Clinical Oncology. 21 (14): 2636–2644. doi:10.1200/JCO.2003.11.136. PMID 12860938.
Santoro A, O'Brien ME, Stahel RA, Nackaerts K, Baas P, Karthaus M, et al. (July 2008). "Pemetrexed plus cisplatin or pemetrexed plus carboplatin for chemonaïve patients with malignant pleural mesothelioma: results of the International Expanded Access Program". Journal of Thoracic Oncology. 3 (7): 756–763. doi:10.1097/JTO.0b013e31817c73d6. PMID 18594322. S2CID 29137806.
Green J, Dundar Y, Dodd S, Dickson R, Walley T (January 2007). Green JA (ed.). "Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma". The Cochrane Database of Systematic Reviews. 2012 (1): CD005574. doi:10.1002/14651858.CD005574.pub2. PMC 8895712. PMID 17253564.
Sugarbaker PH, Welch LS, Mohamed F, Glehen O (July 2003). "A review of peritoneal mesothelioma at the Washington Cancer Institute". Surgical Oncology Clinics of North America. 12 (3): 605–621, xi. doi:10.1016/S1055-3207(03)00045-0. PMID 14567020.
Online manual: Sugarbaker PH (November 1998). Management of Peritoneal Surface Malignancy (Third ed.). Grand Rapids, Michigan: The Ludann Company. Archived from the original on 2005-12-28.
Ambrogi MC, Bertoglio P, Aprile V (2018). "Diaphragm and lung–preserving surgery with hyperthermic chemotherapy for malignant pleural mesothelioma: A 10-year experience". The Journal of Thoracic and Cardiovascular Surgery. 155 (4): 1857–1866.e2. doi:10.1016/j.jtcvs.2017.10.070. hdl:11568/888183. PMID 29191688. Retrieved 1 March 2018.
Richards WG, Zellos L, Bueno R, Jaklitsch MT, Jänne PA, Chirieac LR, et al. (April 2006). "Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma". Journal of Clinical Oncology. 24 (10): 1561–1567. doi:10.1200/JCO.2005.04.6813. PMID 16575008.
Abdel-Rahman O, Elsayed Z, Mohamed H, Eltobgy M (January 2018). "Radical multimodality therapy for malignant pleural mesothelioma". The Cochrane Database of Systematic Reviews. 1 (1): CD012605. doi:10.1002/14651858.CD012605.pub2. PMC 6491325. PMID 29309720.
Pass HI, Temeck BK, Kranda K, Steinberg SM, Feuerstein IR (February 1998). "Preoperative tumor volume is associated with outcome in malignant pleural mesothelioma". The Journal of Thoracic and Cardiovascular Surgery. 115 (2): 310–317, discussion 317–318. doi:10.1016/S0022-5223(98)70274-0. PMID 9475525.
Sugarbaker DJ (February 2006). "Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesothelioma". Journal of Thoracic Oncology. 1 (2): 175–176. doi:10.1097/01243894-200602000-00014. PMID 17409850.
Sugarbaker DJ, Jaklitsch MT, Bueno R, Richards W, Lukanich J, Mentzer SJ, et al. (July 2004). "Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies". The Journal of Thoracic and Cardiovascular Surgery. 128 (1): 138–146. doi:10.1016/j.jtcvs.2004.02.021. PMID 15224033.
Bianchi C, Bianchi T (June 2007). "Malignant mesothelioma: global incidence and relationship with asbestos". Industrial Health. 45 (3): 379–387. doi:10.2486/indhealth.45.379. PMID 17634686.
Robinson BW, Lake RA (October 2005). "Advances in malignant mesothelioma". The New England Journal of Medicine. 353 (15): 1591–1603. doi:10.1056/NEJMra050152. PMID 16221782. S2CID 46621520.
Restrepo CS, Vargas D, Ocazionez D, Martínez-Jiménez S, Betancourt Cuellar SL, Gutierrez FR (October 2013). "Primary pericardial tumors". Radiographics. 33 (6): 1613–1630. doi:10.1148/rg.336135512. PMID 24108554.
Boffetta P (June 2007). "Epidemiology of peritoneal mesothelioma: a review". Annals of Oncology. 18 (6): 985–990. doi:10.1093/annonc/mdl345. PMID 17030547.
Wagner J, Sleggs C, Marchard P (1960). "Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province". Occupational and Environmental Medicine. 17 (4): 260–271. doi:10.1136/oem.17.4.260. PMC 1038078. PMID 13782506.
Gould SJ (2013). "The Median Isn't the Message". AMA Journal of Ethics. 15 (1): 77–81. doi:10.1001/virtualmentor.2013.15.1.mnar1-1301. PMID 23356812.
Wagner JC, Sleggs CA, Marchand P (October 1960). "Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province". British Journal of Industrial Medicine. 17 (4): 260–271. doi:10.1136/oem.17.4.260. PMC 1038078. PMID 13782506.
Moore AJ, Parker RJ, Wiggins J (December 2008). "Malignant mesothelioma". Orphanet Journal of Rare Diseases. 3: 34. doi:10.1186/1750-1172-3-34. PMC 2652430. PMID 19099560.
Mcnulty JC (December 1962). "Malignant pleural mesothelioma in an asbestos worker". The Medical Journal of Australia. 49 (2): 953–954. doi:10.5694/j.1326-5377.1962.tb24396.x. PMID 13932248. S2CID 40173789.

epa.gov

"Learn About Asbestos". US Environmental Protection Agency. 2013-03-05. Archived from the original on 2016-06-23. Retrieved 2016-07-08.

fda.gov

"FDA Approves Drug Combination for Treating Mesothelioma". U.S. Food and Drug Administration (FDA) (Press release). 2 October 2020. Retrieved 2 October 2020. This article incorporates text from this source, which is in the public domain.

handle.net

hdl.handle.net

Burdorf A, Dahhan M, Swuste P (August 2003). "Occupational characteristics of cases with asbestos-related diseases in The Netherlands". The Annals of Occupational Hygiene. 47 (6): 485–492. doi:10.1093/annhyg/meg062. hdl:1765/10196. PMID 12890657.
Milosevic V, Kopecka J, Salaroglio IC, Libener R, Napoli F, Izzo S, et al. (2020). "Wnt/IL-1β/IL-8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5". International Journal of Cancer. 146 (1): 192–207. doi:10.1002/ijc.32419. hdl:2318/1711962. PMID 31107974. S2CID 160014053.
Ambrogi MC, Bertoglio P, Aprile V (2018). "Diaphragm and lung–preserving surgery with hyperthermic chemotherapy for malignant pleural mesothelioma: A 10-year experience". The Journal of Thoracic and Cardiovascular Surgery. 155 (4): 1857–1866.e2. doi:10.1016/j.jtcvs.2017.10.070. hdl:11568/888183. PMID 29191688. Retrieved 1 March 2018.

harvard.edu

ui.adsabs.harvard.edu

Peipins LA, Lewin M, Campolucci S, Lybarger JA, Miller A, Middleton D, et al. (November 2003). "Radiographic abnormalities and exposure to asbestos-contaminated vermiculite in the community of Libby, Montana, USA". Environmental Health Perspectives. 111 (14): 1753–1759. Bibcode:2003EnvHP.111.1753P. doi:10.1289/ehp.6346. PMC 1241719. PMID 14594627.
Miserocchi G, Sancini G, Mantegazza F, Chiappino G (January 2008). "Translocation pathways for inhaled asbestos fibers". Environmental Health. 7 (1): 4. Bibcode:2008EnvHe...7....4M. doi:10.1186/1476-069X-7-4. PMC 2265277. PMID 18218073.

hse.gov.uk

"Where can you find asbestos?". hse.gov.uk. Archived from the original on 2022-07-03. Retrieved 2022-06-27.

independent.co.uk

"McLaren to be buried at Highgate". The Independent. 10 April 2010. Archived from the original on 2017-08-19. Retrieved 13 February 2017.

iol.co.za

"FW de Klerk diagnosed with cancer, undergoes treatment".

jtcvs.org

Tilleman RT, Richards WG (2009). "Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: A phase II prospective study". JTCVS. 138 (2): 405–11. doi:10.1016/j.jtcvs.2009.02.046. PMID 19619785.

junehancockfund.org

"June Hancock Research Fund". Archived from the original on 2010-01-28. Retrieved 2010-03-01.

kb.nl

resolver.kb.nl

"ROGIER VAN OTTERLOO OVERLEDEN". De Telegraaf. 31120. 30 January 1988. Retrieved 13 January 2019.

laweekly.com

Bradley PT (2016-07-05). "Asbestos Killed Warren Zevon — Now His Son Is Fighting to Ban It Once and for All". L.A. Weekly. Archived from the original on 2016-11-16. Retrieved 2017-05-13.

mountsinai.org

"EBSCO database". Archived from the original on 2012-05-12. verified by URAC; accessed from Mount Sinai Hospital, New York

newcastleherald.com.au

Branley A (7 May 2013). "Survivor sees his illness as a 'gift'". Herald News. Archived from the original on 12 November 2014. Retrieved 7 May 2013.

nih.gov

pubmed.ncbi.nlm.nih.gov

Kondola S, Manners D, Nowak AK (June 2016). "Malignant pleural mesothelioma: an update on diagnosis and treatment options". Therapeutic Advances in Respiratory Disease. 10 (3): 275–288. doi:10.1177/1753465816628800. PMC 5933604. PMID 26873306.
Robinson BM (November 2012). "Malignant pleural mesothelioma: an epidemiological perspective". Annals of Cardiothoracic Surgery. 1 (4): 491–496. doi:10.3978/j.issn.2225-319X.2012.11.04. PMC 3741803. PMID 23977542.
Vilchez RA, Butel JS (July 2004). "Emergent human pathogen simian virus 40 and its role in cancer". Clinical Microbiology Reviews. 17 (3): 495–508. doi:10.1128/CMR.17.3.495-508.2004. PMC 452549. PMID 15258090.
Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, et al. (GBD 2015 Disease and Injury Incidence and Prevalence Collaborators) (October 2016). "Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577. PMID 27733282.
Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al. (GBD 2015 Mortality and Causes of Death Collaborators) (October 2016). "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1459–1544. doi:10.1016/s0140-6736(16)31012-1. PMC 5388903. PMID 27733281.
Sardar MR, Kuntz C, Patel T, Saeed W, Gnall E, Imaizumi S, et al. (2012). "Primary pericardial mesothelioma unique case and literature review". Texas Heart Institute Journal. 39 (2): 261–264. PMC 3384041. PMID 22740748.
Panou V, Vyberg M, Weinreich UM, Meristoudis C, Falkmer UG, Røe OD (June 2015). "The established and future biomarkers of malignant pleural mesothelioma". Cancer Treatment Reviews. 41 (6): 486–495. doi:10.1016/j.ctrv.2015.05.001. PMID 25979846.
Gulati M, Redlich CA (March 2015). "Asbestosis and environmental causes of usual interstitial pneumonia". Current Opinion in Pulmonary Medicine. 21 (2): 193–200. doi:10.1097/MCP.0000000000000144. PMC 4472384. PMID 25621562.
Barreiro TJ, Katzman PJ (December 2006). "Malignant mesothelioma: a case presentation and review". The Journal of the American Osteopathic Association. 106 (12): 699–704. PMID 17242414.
Raza A, Huang WC, Takabe K (September 2014). "Advances in the management of peritoneal mesothelioma". World Journal of Gastroenterology. 20 (33): 11700–11712. doi:10.3748/wjg.v20.i33.11700. PMC 4155360. PMID 25206274.
Cedrés S, Fariñas L, Stejpanovic N, Martinez P, Martinez A, Zamora E, et al. (April 2013). "Bone metastases with nerve root compression as a late complication in patient with epithelial pleural mesothelioma". Journal of Thoracic Disease. 5 (2): E35 – E37. doi:10.3978/j.issn.2072-1439.2012.07.08. PMC 3621936. PMID 23585954.
Attanoos RL, Churg A, Galateau-Salle F, Gibbs AR, Roggli VL (June 2018). "Malignant Mesothelioma and Its Non-Asbestos Causes". Archives of Pathology & Laboratory Medicine. 142 (6): 753–760. doi:10.5858/arpa.2017-0365-RA. PMID 29480760.
Constantopoulos SH (October 2008). "Environmental mesothelioma associated with tremolite asbestos: lessons from the experiences of Turkey, Greece, Corsica, New Caledonia and Cyprus". Regulatory Toxicology and Pharmacology. 52 (1 Suppl): S110 – S115. doi:10.1016/j.yrtph.2007.11.001. PMID 18171598.
Carbone M, Emri S, Dogan AU, Steele I, Tuncer M, Pass HI, et al. (February 2007). "A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes". Nature Reviews. Cancer. 7 (2): 147–154. doi:10.1038/nrc2068. PMID 17251920. S2CID 9440201.
Kanarek MS (September 2011). "Mesothelioma from chrysotile asbestos: update". Annals of Epidemiology. 21 (9): 688–697. doi:10.1016/j.annepidem.2011.05.010. PMID 21820631.
Roggli VL, Sharma A, Butnor KJ, Sporn T, Vollmer RT (2002). "Malignant mesothelioma and occupational exposure to asbestos: a clinicopathological correlation of 1445 cases". Ultrastructural Pathology. 26 (2): 55–65. doi:10.1080/01913120252959227. PMID 12036093. S2CID 25204873.
Gennaro V, Finkelstein MM, Ceppi M, Fontana V, Montanaro F, Perrotta A, et al. (March 2000). "Mesothelioma and lung tumors attributable to asbestos among petroleum workers". American Journal of Industrial Medicine. 37 (3): 275–282. doi:10.1002/(SICI)1097-0274(200003)37:3<275::AID-AJIM5>3.0.CO;2-I. PMID 10642417.
Henderson DW, Rödelsperger K, Woitowitz HJ, Leigh J (December 2004). "After Helsinki: a multidisciplinary review of the relationship between asbestos exposure and lung cancer, with emphasis on studies published during 1997–2004". Pathology. 36 (6): 517–550. doi:10.1080/00313020400010955. PMID 15841689. S2CID 35280387.
Hillerdal G (August 1999). "Mesothelioma: cases associated with non-occupational and low dose exposures". Occupational and Environmental Medicine. 56 (8): 505–513. doi:10.1136/oem.56.8.505. PMC 1757769. PMID 10492646.
Peto J, Seidman H, Selikoff IJ (January 1982). "Mesothelioma mortality in asbestos workers: implications for models of carcinogenesis and risk assessment". British Journal of Cancer. 45 (1): 124–135. doi:10.1038/bjc.1982.15. PMC 2010947. PMID 7059455.
Carbone M, Ly BH, Dodson RF, Pagano I, Morris PT, Dogan UA, et al. (January 2012). "Malignant mesothelioma: facts, myths, and hypotheses". Journal of Cellular Physiology. 227 (1): 44–58. doi:10.1002/jcp.22724. PMC 3143206. PMID 21412769.
Lanphear BP, Buncher CR (July 1992). "Latent period for malignant mesothelioma of occupational origin". Journal of Occupational Medicine. 34 (7): 718–721. PMID 1494965.
Burdorf A, Dahhan M, Swuste P (August 2003). "Occupational characteristics of cases with asbestos-related diseases in The Netherlands". The Annals of Occupational Hygiene. 47 (6): 485–492. doi:10.1093/annhyg/meg062. hdl:1765/10196. PMID 12890657.
Glover J (April 1973). "Hygiene standards for airborne amosite asbestos dust. British Occupational Hygiene Society Committee on Hygiene Standards". The Annals of Occupational Hygiene. 16 (1): 1–5. doi:10.1093/annhyg/16.1.1. PMID 4775386.
Berry G, Reid A, Aboagye-Sarfo P, de Klerk NH, Olsen NJ, Merler E, et al. (February 2012). "Malignant mesotheliomas in former miners and millers of crocidolite at Wittenoom (Western Australia) after more than 50 years follow-up". British Journal of Cancer. 106 (5): 1016–1020. doi:10.1038/bjc.2012.23. PMC 3305966. PMID 22315054.
Peipins LA, Lewin M, Campolucci S, Lybarger JA, Miller A, Middleton D, et al. (November 2003). "Radiographic abnormalities and exposure to asbestos-contaminated vermiculite in the community of Libby, Montana, USA". Environmental Health Perspectives. 111 (14): 1753–1759. Bibcode:2003EnvHP.111.1753P. doi:10.1289/ehp.6346. PMC 1241719. PMID 14594627.
Testa JR, Cheung M, Pei J, Below JE, Tan Y, Sementino E, et al. (August 2011). "Germline BAP1 mutations predispose to malignant mesothelioma". Nature Genetics. 43 (10): 1022–1025. doi:10.1038/ng.912. PMC 3184199. PMID 21874000.
Mutsaers SE (September 2002). "Mesothelial cells: their structure, function and role in serosal repair". Respirology. 7 (3): 171–191. doi:10.1046/j.1440-1843.2002.00404.x. PMID 12153683. S2CID 23976724.
Miserocchi G, Sancini G, Mantegazza F, Chiappino G (January 2008). "Translocation pathways for inhaled asbestos fibers". Environmental Health. 7 (1): 4. Bibcode:2008EnvHe...7....4M. doi:10.1186/1476-069X-7-4. PMC 2265277. PMID 18218073.
Chiosea S, Krasinskas A, Cagle PT, Mitchell KA, Zander DS, Dacic S (June 2008). "Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas". Modern Pathology. 21 (6): 742–747. doi:10.1038/modpathol.2008.45. PMID 18327208. S2CID 7743919.
Sherr CJ (September 2006). "Divorcing ARF and p53: an unsettled case". Nature Reviews. Cancer. 6 (9): 663–673. doi:10.1038/nrc1954. PMID 16915296. S2CID 29465278.
Dehé PM, Gaillard PH (May 2017). "Control of structure-specific endonucleases to maintain genome stability". Nature Reviews Molecular Cell Biology. 18 (5): 315–330. doi:10.1038/nrm.2016.177. PMID 28327556. S2CID 24009279.
Bueno, Stawiski, Goldstein, Durinck, De Rienzo (2016). "Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations". Nature Genetics. 48 (4): 407–416. doi:10.1038/ng.3520. PMID 26928227. S2CID 13480173.
Mangiante, Alcala, Sexton-Oates, Di Genova, Gonzalez-Perez (2023). "Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity". Nature Genetics. 55 (4): 607–618. doi:10.1038/s41588-023-01321-1. PMC 10101853. PMID 36928603. S2CID 257582839.
Davidson B (June 2015). "Prognostic factors in malignant pleural mesothelioma". Human Pathology. 46 (6): 789–804. doi:10.1016/j.humpath.2015.02.006. PMID 25824607.
Reid G (June 2015). "MicroRNAs in mesothelioma: from tumour suppressors and biomarkers to therapeutic targets". Journal of Thoracic Disease. 7 (6): 1031–1040. doi:10.3978/j.issn.2072-1439.2015.04.56. PMC 4466421. PMID 26150916.
Comertpay S, Pastorino S, Tanji M, Mezzapelle R, Strianese O, Napolitano A, et al. (December 2014). "Evaluation of clonal origin of malignant mesothelioma". Journal of Translational Medicine. 12: 301. doi:10.1186/s12967-014-0301-3. PMC 4255423. PMID 25471750.
Weder W (October 2010). "Mesothelioma". Annals of Oncology. 21 (7): vii326 – vii333. doi:10.1093/annonc/mdq471. PMID 20943637.
Ceresoli GL, Gridelli C, Santoro A (July 2007). "Multidisciplinary treatment of malignant pleural mesothelioma". The Oncologist. 12 (7): 850–863. doi:10.1634/theoncologist.12-7-850. PMID 17673616. S2CID 41668550.
Berzenji L, Van Schil PE, Carp L (October 2018). "The eighth TNM classification for malignant pleural mesothelioma". Translational Lung Cancer Research. 7 (5): 543–549. doi:10.21037/tlcr.2018.07.05. PMC 6204412. PMID 30450292.
Robinson BW, Creaney J, Lake R, Nowak A, Musk AW, de Klerk N, et al. (July 2005). "Soluble mesothelin-related protein--a blood test for mesothelioma". Lung Cancer. 49 (Suppl 1): S109 – S111. doi:10.1016/j.lungcan.2005.03.020. PMID 15950789.
Beyer HL, Geschwindt RD, Glover CL, Tran L, Hellstrom I, Hellstrom KE, et al. (April 2007). "MESOMARK: a potential test for malignant pleural mesothelioma". Clinical Chemistry. 53 (4): 666–672. doi:10.1373/clinchem.2006.079327. PMID 17289801.
Milosevic V, Kopecka J, Salaroglio IC, Libener R, Napoli F, Izzo S, et al. (2020). "Wnt/IL-1β/IL-8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5". International Journal of Cancer. 146 (1): 192–207. doi:10.1002/ijc.32419. hdl:2318/1711962. PMID 31107974. S2CID 160014053.
Haber SE, Haber JM (2011). "Malignant mesothelioma: a clinical study of 238 cases". Industrial Health. 49 (2): 166–172. doi:10.2486/indhealth.MS1147. PMID 21173534.
Chapman E, Berenstein EG, Diéguez M, Ortiz Z (July 2006). "Radiotherapy for malignant pleural mesothelioma". The Cochrane Database of Systematic Reviews. 2010 (3): CD003880. doi:10.1002/14651858.CD003880.pub4. PMC 8746191. PMID 16856023. S2CID 26025607.
Borasio P, Berruti A, Billé A, Lausi P, Levra MG, Giardino R, et al. (February 2008). "Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients". European Journal of Cardio-Thoracic Surgery. 33 (2): 307–313. doi:10.1016/j.ejcts.2007.09.044. PMID 18164622.
Tilleman RT, Richards WG (2009). "Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: A phase II prospective study". JTCVS. 138 (2): 405–11. doi:10.1016/j.jtcvs.2009.02.046. PMID 19619785.
Allen AM, Czerminska M, Jänne PA, Sugarbaker DJ, Bueno R, Harris JR, et al. (1 July 2006). "Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma". International Journal of Radiation Oncology, Biology, Physics. 65 (3): 640–645. doi:10.1016/j.ijrobp.2006.03.012. PMID 16751058.
Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, et al. (July 2003). "Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma". Journal of Clinical Oncology. 21 (14): 2636–2644. doi:10.1200/JCO.2003.11.136. PMID 12860938.
Santoro A, O'Brien ME, Stahel RA, Nackaerts K, Baas P, Karthaus M, et al. (July 2008). "Pemetrexed plus cisplatin or pemetrexed plus carboplatin for chemonaïve patients with malignant pleural mesothelioma: results of the International Expanded Access Program". Journal of Thoracic Oncology. 3 (7): 756–763. doi:10.1097/JTO.0b013e31817c73d6. PMID 18594322. S2CID 29137806.
Green J, Dundar Y, Dodd S, Dickson R, Walley T (January 2007). Green JA (ed.). "Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma". The Cochrane Database of Systematic Reviews. 2012 (1): CD005574. doi:10.1002/14651858.CD005574.pub2. PMC 8895712. PMID 17253564.
Sugarbaker PH, Welch LS, Mohamed F, Glehen O (July 2003). "A review of peritoneal mesothelioma at the Washington Cancer Institute". Surgical Oncology Clinics of North America. 12 (3): 605–621, xi. doi:10.1016/S1055-3207(03)00045-0. PMID 14567020.
Online manual: Sugarbaker PH (November 1998). Management of Peritoneal Surface Malignancy (Third ed.). Grand Rapids, Michigan: The Ludann Company. Archived from the original on 2005-12-28.
Ambrogi MC, Bertoglio P, Aprile V (2018). "Diaphragm and lung–preserving surgery with hyperthermic chemotherapy for malignant pleural mesothelioma: A 10-year experience". The Journal of Thoracic and Cardiovascular Surgery. 155 (4): 1857–1866.e2. doi:10.1016/j.jtcvs.2017.10.070. hdl:11568/888183. PMID 29191688. Retrieved 1 March 2018.
Richards WG, Zellos L, Bueno R, Jaklitsch MT, Jänne PA, Chirieac LR, et al. (April 2006). "Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma". Journal of Clinical Oncology. 24 (10): 1561–1567. doi:10.1200/JCO.2005.04.6813. PMID 16575008.
Abdel-Rahman O, Elsayed Z, Mohamed H, Eltobgy M (January 2018). "Radical multimodality therapy for malignant pleural mesothelioma". The Cochrane Database of Systematic Reviews. 1 (1): CD012605. doi:10.1002/14651858.CD012605.pub2. PMC 6491325. PMID 29309720.
Pass HI, Temeck BK, Kranda K, Steinberg SM, Feuerstein IR (February 1998). "Preoperative tumor volume is associated with outcome in malignant pleural mesothelioma". The Journal of Thoracic and Cardiovascular Surgery. 115 (2): 310–317, discussion 317–318. doi:10.1016/S0022-5223(98)70274-0. PMID 9475525.
Sugarbaker DJ (February 2006). "Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesothelioma". Journal of Thoracic Oncology. 1 (2): 175–176. doi:10.1097/01243894-200602000-00014. PMID 17409850.
Sugarbaker DJ, Jaklitsch MT, Bueno R, Richards W, Lukanich J, Mentzer SJ, et al. (July 2004). "Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies". The Journal of Thoracic and Cardiovascular Surgery. 128 (1): 138–146. doi:10.1016/j.jtcvs.2004.02.021. PMID 15224033.
Bianchi C, Bianchi T (June 2007). "Malignant mesothelioma: global incidence and relationship with asbestos". Industrial Health. 45 (3): 379–387. doi:10.2486/indhealth.45.379. PMID 17634686.
Robinson BW, Lake RA (October 2005). "Advances in malignant mesothelioma". The New England Journal of Medicine. 353 (15): 1591–1603. doi:10.1056/NEJMra050152. PMID 16221782. S2CID 46621520.
Restrepo CS, Vargas D, Ocazionez D, Martínez-Jiménez S, Betancourt Cuellar SL, Gutierrez FR (October 2013). "Primary pericardial tumors". Radiographics. 33 (6): 1613–1630. doi:10.1148/rg.336135512. PMID 24108554.
Boffetta P (June 2007). "Epidemiology of peritoneal mesothelioma: a review". Annals of Oncology. 18 (6): 985–990. doi:10.1093/annonc/mdl345. PMID 17030547.
Wagner J, Sleggs C, Marchard P (1960). "Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province". Occupational and Environmental Medicine. 17 (4): 260–271. doi:10.1136/oem.17.4.260. PMC 1038078. PMID 13782506.
Gould SJ (2013). "The Median Isn't the Message". AMA Journal of Ethics. 15 (1): 77–81. doi:10.1001/virtualmentor.2013.15.1.mnar1-1301. PMID 23356812.
Wagner JC, Sleggs CA, Marchand P (October 1960). "Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province". British Journal of Industrial Medicine. 17 (4): 260–271. doi:10.1136/oem.17.4.260. PMC 1038078. PMID 13782506.
Moore AJ, Parker RJ, Wiggins J (December 2008). "Malignant mesothelioma". Orphanet Journal of Rare Diseases. 3: 34. doi:10.1186/1750-1172-3-34. PMC 2652430. PMID 19099560.
Mcnulty JC (December 1962). "Malignant pleural mesothelioma in an asbestos worker". The Medical Journal of Australia. 49 (2): 953–954. doi:10.5694/j.1326-5377.1962.tb24396.x. PMID 13932248. S2CID 40173789.
Mott FE (2012). "Mesothelioma: a review". The Ochsner Journal. 12 (1): 70–79. PMC 3307510. PMID 22438785.

ncbi.nlm.nih.gov

Kondola S, Manners D, Nowak AK (June 2016). "Malignant pleural mesothelioma: an update on diagnosis and treatment options". Therapeutic Advances in Respiratory Disease. 10 (3): 275–288. doi:10.1177/1753465816628800. PMC 5933604. PMID 26873306.
Robinson BM (November 2012). "Malignant pleural mesothelioma: an epidemiological perspective". Annals of Cardiothoracic Surgery. 1 (4): 491–496. doi:10.3978/j.issn.2225-319X.2012.11.04. PMC 3741803. PMID 23977542.
Vilchez RA, Butel JS (July 2004). "Emergent human pathogen simian virus 40 and its role in cancer". Clinical Microbiology Reviews. 17 (3): 495–508. doi:10.1128/CMR.17.3.495-508.2004. PMC 452549. PMID 15258090.
Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, et al. (GBD 2015 Disease and Injury Incidence and Prevalence Collaborators) (October 2016). "Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577. PMID 27733282.
Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al. (GBD 2015 Mortality and Causes of Death Collaborators) (October 2016). "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1459–1544. doi:10.1016/s0140-6736(16)31012-1. PMC 5388903. PMID 27733281.
Sardar MR, Kuntz C, Patel T, Saeed W, Gnall E, Imaizumi S, et al. (2012). "Primary pericardial mesothelioma unique case and literature review". Texas Heart Institute Journal. 39 (2): 261–264. PMC 3384041. PMID 22740748.
Gulati M, Redlich CA (March 2015). "Asbestosis and environmental causes of usual interstitial pneumonia". Current Opinion in Pulmonary Medicine. 21 (2): 193–200. doi:10.1097/MCP.0000000000000144. PMC 4472384. PMID 25621562.
Raza A, Huang WC, Takabe K (September 2014). "Advances in the management of peritoneal mesothelioma". World Journal of Gastroenterology. 20 (33): 11700–11712. doi:10.3748/wjg.v20.i33.11700. PMC 4155360. PMID 25206274.
Cedrés S, Fariñas L, Stejpanovic N, Martinez P, Martinez A, Zamora E, et al. (April 2013). "Bone metastases with nerve root compression as a late complication in patient with epithelial pleural mesothelioma". Journal of Thoracic Disease. 5 (2): E35 – E37. doi:10.3978/j.issn.2072-1439.2012.07.08. PMC 3621936. PMID 23585954.
Hillerdal G (August 1999). "Mesothelioma: cases associated with non-occupational and low dose exposures". Occupational and Environmental Medicine. 56 (8): 505–513. doi:10.1136/oem.56.8.505. PMC 1757769. PMID 10492646.
Peto J, Seidman H, Selikoff IJ (January 1982). "Mesothelioma mortality in asbestos workers: implications for models of carcinogenesis and risk assessment". British Journal of Cancer. 45 (1): 124–135. doi:10.1038/bjc.1982.15. PMC 2010947. PMID 7059455.
Carbone M, Ly BH, Dodson RF, Pagano I, Morris PT, Dogan UA, et al. (January 2012). "Malignant mesothelioma: facts, myths, and hypotheses". Journal of Cellular Physiology. 227 (1): 44–58. doi:10.1002/jcp.22724. PMC 3143206. PMID 21412769.
Berry G, Reid A, Aboagye-Sarfo P, de Klerk NH, Olsen NJ, Merler E, et al. (February 2012). "Malignant mesotheliomas in former miners and millers of crocidolite at Wittenoom (Western Australia) after more than 50 years follow-up". British Journal of Cancer. 106 (5): 1016–1020. doi:10.1038/bjc.2012.23. PMC 3305966. PMID 22315054.
Peipins LA, Lewin M, Campolucci S, Lybarger JA, Miller A, Middleton D, et al. (November 2003). "Radiographic abnormalities and exposure to asbestos-contaminated vermiculite in the community of Libby, Montana, USA". Environmental Health Perspectives. 111 (14): 1753–1759. Bibcode:2003EnvHP.111.1753P. doi:10.1289/ehp.6346. PMC 1241719. PMID 14594627.
Testa JR, Cheung M, Pei J, Below JE, Tan Y, Sementino E, et al. (August 2011). "Germline BAP1 mutations predispose to malignant mesothelioma". Nature Genetics. 43 (10): 1022–1025. doi:10.1038/ng.912. PMC 3184199. PMID 21874000.
Miserocchi G, Sancini G, Mantegazza F, Chiappino G (January 2008). "Translocation pathways for inhaled asbestos fibers". Environmental Health. 7 (1): 4. Bibcode:2008EnvHe...7....4M. doi:10.1186/1476-069X-7-4. PMC 2265277. PMID 18218073.
Mangiante, Alcala, Sexton-Oates, Di Genova, Gonzalez-Perez (2023). "Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity". Nature Genetics. 55 (4): 607–618. doi:10.1038/s41588-023-01321-1. PMC 10101853. PMID 36928603. S2CID 257582839.
Reid G (June 2015). "MicroRNAs in mesothelioma: from tumour suppressors and biomarkers to therapeutic targets". Journal of Thoracic Disease. 7 (6): 1031–1040. doi:10.3978/j.issn.2072-1439.2015.04.56. PMC 4466421. PMID 26150916.
Comertpay S, Pastorino S, Tanji M, Mezzapelle R, Strianese O, Napolitano A, et al. (December 2014). "Evaluation of clonal origin of malignant mesothelioma". Journal of Translational Medicine. 12: 301. doi:10.1186/s12967-014-0301-3. PMC 4255423. PMID 25471750.
Berzenji L, Van Schil PE, Carp L (October 2018). "The eighth TNM classification for malignant pleural mesothelioma". Translational Lung Cancer Research. 7 (5): 543–549. doi:10.21037/tlcr.2018.07.05. PMC 6204412. PMID 30450292.
Chapman E, Berenstein EG, Diéguez M, Ortiz Z (July 2006). "Radiotherapy for malignant pleural mesothelioma". The Cochrane Database of Systematic Reviews. 2010 (3): CD003880. doi:10.1002/14651858.CD003880.pub4. PMC 8746191. PMID 16856023. S2CID 26025607.
Green J, Dundar Y, Dodd S, Dickson R, Walley T (January 2007). Green JA (ed.). "Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma". The Cochrane Database of Systematic Reviews. 2012 (1): CD005574. doi:10.1002/14651858.CD005574.pub2. PMC 8895712. PMID 17253564.
Abdel-Rahman O, Elsayed Z, Mohamed H, Eltobgy M (January 2018). "Radical multimodality therapy for malignant pleural mesothelioma". The Cochrane Database of Systematic Reviews. 1 (1): CD012605. doi:10.1002/14651858.CD012605.pub2. PMC 6491325. PMID 29309720.
Wagner J, Sleggs C, Marchard P (1960). "Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province". Occupational and Environmental Medicine. 17 (4): 260–271. doi:10.1136/oem.17.4.260. PMC 1038078. PMID 13782506.
Wagner JC, Sleggs CA, Marchand P (October 1960). "Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province". British Journal of Industrial Medicine. 17 (4): 260–271. doi:10.1136/oem.17.4.260. PMC 1038078. PMID 13782506.
Moore AJ, Parker RJ, Wiggins J (December 2008). "Malignant mesothelioma". Orphanet Journal of Rare Diseases. 3: 34. doi:10.1186/1750-1172-3-34. PMC 2652430. PMID 19099560.
Mott FE (2012). "Mesothelioma: a review". The Ochsner Journal. 12 (1): 70–79. PMC 3307510. PMID 22438785.

ninds.nih.gov

"Neurofibromatosis Fact Sheet". NINDS. 3 February 2016. Archived from the original on 23 January 2018. Retrieved 16 April 2018. This article incorporates text from this source, which is in the public domain.

nytimes.com

Lerner BH (2005-11-15). "McQueen's Legacy of Laetrile". The New York Times. Archived from the original on August 11, 2010. Retrieved May 12, 2010.
"Paul Gleason, 67, 'Breakfast Club' Actor, Is Dead". The New York Times. No. 29 May 2016. Associated Press. 29 May 2006. Retrieved 3 July 2021.

prwatch.org

"The Junkman's Answer to Terrorism: Use More Asbestos" (PDF). Center for Media and Democracy: Prwatch.org. 2001. Archived (PDF) from the original on 2011-10-16. Retrieved 2010-08-20.

rand.org

"Asbestos Litigation Costs and Compensation: An Interim Report" (PDF). Archived from the original (PDF) on 2009-04-24. Retrieved 2010-08-20.

rcn.com

users.rcn.com

"Oncogenes". Kimball's Biology Pages. Archived from the original on 2017-12-31.

scientificamerican.com

"Study says Carbon Nanotubes as Dangerous as Asbestos". Scientific American.

semanticscholar.org

api.semanticscholar.org

Dogan U (2003). "Mesothelioma in Cappadocian villages". Indoor and Built Environment. 12 (6): 367–375. doi:10.1177/1420326X03039065. ISSN 1420-326X. S2CID 110334356.
Carbone M, Emri S, Dogan AU, Steele I, Tuncer M, Pass HI, et al. (February 2007). "A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes". Nature Reviews. Cancer. 7 (2): 147–154. doi:10.1038/nrc2068. PMID 17251920. S2CID 9440201.
Roggli VL, Sharma A, Butnor KJ, Sporn T, Vollmer RT (2002). "Malignant mesothelioma and occupational exposure to asbestos: a clinicopathological correlation of 1445 cases". Ultrastructural Pathology. 26 (2): 55–65. doi:10.1080/01913120252959227. PMID 12036093. S2CID 25204873.
Henderson DW, Rödelsperger K, Woitowitz HJ, Leigh J (December 2004). "After Helsinki: a multidisciplinary review of the relationship between asbestos exposure and lung cancer, with emphasis on studies published during 1997–2004". Pathology. 36 (6): 517–550. doi:10.1080/00313020400010955. PMID 15841689. S2CID 35280387.
Mutsaers SE (September 2002). "Mesothelial cells: their structure, function and role in serosal repair". Respirology. 7 (3): 171–191. doi:10.1046/j.1440-1843.2002.00404.x. PMID 12153683. S2CID 23976724.
Chiosea S, Krasinskas A, Cagle PT, Mitchell KA, Zander DS, Dacic S (June 2008). "Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas". Modern Pathology. 21 (6): 742–747. doi:10.1038/modpathol.2008.45. PMID 18327208. S2CID 7743919.
Sherr CJ (September 2006). "Divorcing ARF and p53: an unsettled case". Nature Reviews. Cancer. 6 (9): 663–673. doi:10.1038/nrc1954. PMID 16915296. S2CID 29465278.
Dehé PM, Gaillard PH (May 2017). "Control of structure-specific endonucleases to maintain genome stability". Nature Reviews Molecular Cell Biology. 18 (5): 315–330. doi:10.1038/nrm.2016.177. PMID 28327556. S2CID 24009279.
Bueno, Stawiski, Goldstein, Durinck, De Rienzo (2016). "Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations". Nature Genetics. 48 (4): 407–416. doi:10.1038/ng.3520. PMID 26928227. S2CID 13480173.
Mangiante, Alcala, Sexton-Oates, Di Genova, Gonzalez-Perez (2023). "Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity". Nature Genetics. 55 (4): 607–618. doi:10.1038/s41588-023-01321-1. PMC 10101853. PMID 36928603. S2CID 257582839.
Ceresoli GL, Gridelli C, Santoro A (July 2007). "Multidisciplinary treatment of malignant pleural mesothelioma". The Oncologist. 12 (7): 850–863. doi:10.1634/theoncologist.12-7-850. PMID 17673616. S2CID 41668550.
Milosevic V, Kopecka J, Salaroglio IC, Libener R, Napoli F, Izzo S, et al. (2020). "Wnt/IL-1β/IL-8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5". International Journal of Cancer. 146 (1): 192–207. doi:10.1002/ijc.32419. hdl:2318/1711962. PMID 31107974. S2CID 160014053.
Chapman E, Berenstein EG, Diéguez M, Ortiz Z (July 2006). "Radiotherapy for malignant pleural mesothelioma". The Cochrane Database of Systematic Reviews. 2010 (3): CD003880. doi:10.1002/14651858.CD003880.pub4. PMC 8746191. PMID 16856023. S2CID 26025607.
Santoro A, O'Brien ME, Stahel RA, Nackaerts K, Baas P, Karthaus M, et al. (July 2008). "Pemetrexed plus cisplatin or pemetrexed plus carboplatin for chemonaïve patients with malignant pleural mesothelioma: results of the International Expanded Access Program". Journal of Thoracic Oncology. 3 (7): 756–763. doi:10.1097/JTO.0b013e31817c73d6. PMID 18594322. S2CID 29137806.
Robinson BW, Lake RA (October 2005). "Advances in malignant mesothelioma". The New England Journal of Medicine. 353 (15): 1591–1603. doi:10.1056/NEJMra050152. PMID 16221782. S2CID 46621520.
Mcnulty JC (December 1962). "Malignant pleural mesothelioma in an asbestos worker". The Medical Journal of Australia. 49 (2): 953–954. doi:10.5694/j.1326-5377.1962.tb24396.x. PMID 13932248. S2CID 40173789.

smh.com.au

"Lives in the dust". The Sydney Morning Herald. 25 September 2004.

surgicaloncology.com

Sugarbaker PH, Welch LS, Mohamed F, Glehen O (July 2003). "A review of peritoneal mesothelioma at the Washington Cancer Institute". Surgical Oncology Clinics of North America. 12 (3): 605–621, xi. doi:10.1016/S1055-3207(03)00045-0. PMID 14567020.
Online manual: Sugarbaker PH (November 1998). Management of Peritoneal Surface Malignancy (Third ed.). Grand Rapids, Michigan: The Ludann Company. Archived from the original on 2005-12-28.

utsouthwestern.edu

www4.utsouthwestern.edu

Shay JW, Wright WE. "What are telomeres and telomerase?". The University of Texas Southwestern Medical Center at Dallas. Archived from the original on 10 March 2008.

web.archive.org

"Malignant Mesothelioma Treatment – Patient Version (PDQ®)". NCI. September 4, 2015. Archived from the original on 5 April 2016. Retrieved 3 April 2016.
"Malignant Mesothelioma Treatment – Patient Version (PDQ®)". NCI. September 4, 2015. Archived from the original on 5 April 2016. Retrieved 3 April 2016.
"Age-Adjusted SEER Incidence and U.S. Death Rates and 5-Year Relative Survival (Percent) By Primary Cancer Site, Sex and Time Period" (PDF). NCI. Archived (PDF) from the original on 6 September 2015. Retrieved 3 April 2016.
"Malignant Mesothelioma – Patient Version". NCI. January 1980. Archived from the original on 6 April 2016. Retrieved 3 April 2016.
"What are the key statistics about malignant mesothelioma?". American Cancer Society. 2016-02-17. Archived from the original on 8 April 2016. Retrieved 3 April 2016.
"EBSCO database". Archived from the original on 2012-05-12. verified by URAC; accessed from Mount Sinai Hospital, New York
Weissman D, Kiefer M (22 November 2011). "Erionite: An Emerging North American Hazard". National Institute for Occupational Safety and Health. Archived from the original on 5 September 2015.
"NIOSH Working Group Paper" (PDF). U.S. Centers for Disease Control and prevention. 1980. Archived from the original (PDF) on 2017-06-18.
"Learn About Asbestos". US Environmental Protection Agency. 2013-03-05. Archived from the original on 2016-06-23. Retrieved 2016-07-08.
"Protecting Workers' Families: A Research Agenda of the Workers' Family Protection Task Force". National Institute for Occupational Safety and Health. DHHS (NIOSH). May 2002. Publication No. 2002-113. Archived from the original on 2017-06-19.
"Where can you find asbestos?". hse.gov.uk. Archived from the original on 2022-07-03. Retrieved 2022-06-27.
"The Junkman's Answer to Terrorism: Use More Asbestos" (PDF). Center for Media and Democracy: Prwatch.org. 2001. Archived (PDF) from the original on 2011-10-16. Retrieved 2010-08-20.
"Neurofibromatosis Fact Sheet". NINDS. 3 February 2016. Archived from the original on 23 January 2018. Retrieved 16 April 2018. This article incorporates text from this source, which is in the public domain.
"Oncogenes". Kimball's Biology Pages. Archived from the original on 2017-12-31.
Shay JW, Wright WE. "What are telomeres and telomerase?". The University of Texas Southwestern Medical Center at Dallas. Archived from the original on 10 March 2008.
Sugarbaker PH, Welch LS, Mohamed F, Glehen O (July 2003). "A review of peritoneal mesothelioma at the Washington Cancer Institute". Surgical Oncology Clinics of North America. 12 (3): 605–621, xi. doi:10.1016/S1055-3207(03)00045-0. PMID 14567020.
Online manual: Sugarbaker PH (November 1998). Management of Peritoneal Surface Malignancy (Third ed.). Grand Rapids, Michigan: The Ludann Company. Archived from the original on 2005-12-28.
"Survival statistics for mesothelioma". cancer.org. 17 February 2016. Archived from the original on 6 November 2016. Retrieved 28 November 2016.
"Asbestos Litigation Costs and Compensation: An Interim Report" (PDF). Archived from the original (PDF) on 2009-04-24. Retrieved 2010-08-20.
"Mesothelioma statistics". Cancer Research UK. 2015-05-14. Archived from the original on 30 October 2014. Retrieved 28 October 2014.
"McLaren to be buried at Highgate". The Independent. 10 April 2010. Archived from the original on 2017-08-19. Retrieved 13 February 2017.
Lerner BH (2005-11-15). "McQueen's Legacy of Laetrile". The New York Times. Archived from the original on August 11, 2010. Retrieved May 12, 2010.
Bradley PT (2016-07-05). "Asbestos Killed Warren Zevon — Now His Son Is Fighting to Ban It Once and for All". L.A. Weekly. Archived from the original on 2016-11-16. Retrieved 2017-05-13.
Branley A (7 May 2013). "Survivor sees his illness as a 'gift'". Herald News. Archived from the original on 12 November 2014. Retrieved 7 May 2013.
"H.R.982 - 113th Congress (2013-2014): Furthering Asbestos Claim Transparency (FACT) Act of 2013 - Congress.gov - Library of Congress". Library of Congress. 2013-11-14. Archived from the original on 24 July 2014. Retrieved 20 October 2014.
"H.R.526 - 114th Congress (2015-2016): Furthering Asbestos Claim Transparency (FACT) Act of 2015 - Congress.gov - Library of Congress". Library of Congress. 2015-11-30. Archived from the original on 2015-09-07. Retrieved 1 Dec 2015.
"June Hancock Research Fund". Archived from the original on 2010-01-28. Retrieved 2010-03-01.

who.int

"Asbestos in Drinking-water: Background document for development of WHO Guidelines for Drinking-water quality" (PDF). 2003. Retrieved July 30, 2019.

worldcat.org

search.worldcat.org

Dogan U (2003). "Mesothelioma in Cappadocian villages". Indoor and Built Environment. 12 (6): 367–375. doi:10.1177/1420326X03039065. ISSN 1420-326X. S2CID 110334356.

zenodo.org

Gennaro V, Finkelstein MM, Ceppi M, Fontana V, Montanaro F, Perrotta A, et al. (March 2000). "Mesothelioma and lung tumors attributable to asbestos among petroleum workers". American Journal of Industrial Medicine. 37 (3): 275–282. doi:10.1002/(SICI)1097-0274(200003)37:3<275::AID-AJIM5>3.0.CO;2-I. PMID 10642417.